(Q37561680)

21 August 2017

1 reference

title

Lung disease, antibodies and other unresolved issues in immune globulin therapy for antibody deficiency (English)

1 reference

Charlotte Cunningham-Rundles

21 August 2017

1 reference

1 reference

series ordinal

1

object named as

C Cunningham-Rundles

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

number of pages

5

1 reference

Clinical and Experimental Immunology

inferred from page(s)

published in

1 reference

21 August 2017

volume

157 Suppl 1

1 reference

21 August 2017

page(s)

12-16

1 reference

Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia.

21 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2009.03952.X

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2009.03952.X

Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2009.03952.X

Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Improving mucociliary clearance in chronic obstructive pulmonary disease.

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Macrolide therapy targets a specific phenotype in respiratory medicine: from clinical experience to basic science and back

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Memory B cells in common variable immunodeficiency: clinical associations and sex differences

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

The EUROclass trial: defining subgroups in common variable immunodeficiency.

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

FcRn: the neonatal Fc receptor comes of age.

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter.

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Efficacy of a two-component acellular pertussis vaccine in infants

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

Metabolism of immunoglobulins

17 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715435

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

17 September 2018

1 reference

12 December 2020

Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients

1 reference

12 December 2020

Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency

1 reference

12 December 2020

Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases

1 reference

12 December 2020

A multicenter, prospective, open label, historically controlled clinical trial to evaluate efficacy and safety in primary immunodeficiency diseases (PID) patients of Flebogamma 5% DIF, the next generation of Flebogamma

1 reference

12 December 2020

Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration

1 reference

12 December 2020

Pulmonary abnormalities in patients with primary hypogammaglobulinemia

1 reference

12 December 2020

Common variable immunodeficiency

1 reference

12 December 2020

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

1 reference

12 December 2020

10.1111/J.1365-2249.2009.03952.X

Identifiers

DOI

1 reference

21 August 2017

0 references

1 reference